ALCOHOL, METABOLISMO Y SISTEMA INMUNE
![Foto de ALCOHOL, METABOLISMO Y SISTEMA INMUNE](/img/grupo.png)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital de la Santa Creu i Sant Pau (8)
2020
-
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
The Lancet Infectious Diseases, Vol. 20, Núm. 12, pp. 1409-1417
2019
-
The more you take it, the better it works: Six-month results of a nalmefene phase-IV trial
Journal of Clinical Medicine, Vol. 8, Núm. 4
2018
-
Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?
Clinical Drug Investigation
-
Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results
Clinical Drug Investigation, Vol. 38, Núm. 2, pp. 147-155
2013
-
Driving and legal status of Spanish opioid-dependent patients
Substance Abuse: Treatment, Prevention, and Policy, Vol. 8, Núm. 1
2012
-
Feasibility of double-blind clinical trials with oral diacetylmorphine: A randomized controlled Phase II study in an inpatient setting
European Addiction Research, Vol. 18, Núm. 6, pp. 279-287
2011
-
A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients
Addictive Behaviors, Vol. 36, Núm. 3, pp. 265-269
2004
-
A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder
Alcoholism: Clinical and Experimental Research, Vol. 28, Núm. 5, pp. 736-745